NCT02187419

Brief Summary

The purpose of this study is to determine feasibility and adherence to a hypnosis program to improve sleep. It is theorized (based on prior experience and pilot data) that one or more hypnosis program(s) will be feasible and will exhibit acceptable adherence. The programs will assess to determine optimal dose (3 vs 5 sessions) and method (audio-recorded vs therapist delivered).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 11, 2014

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 24, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2017

Completed
Last Updated

April 13, 2017

Status Verified

April 1, 2017

Enrollment Period

2.2 years

First QC Date

July 9, 2014

Last Update Submit

April 12, 2017

Conditions

Keywords

SleepMenopauseHypnosisRelaxationHypnotic Relaxation TherapyHot Flash

Outcome Measures

Primary Outcomes (1)

  • Objective sleep duration

    Wrist actigraphy: Wrist actigraphy is a widely used and well-validated, objective measure of sleep duration. Participants will be asked to wear an Actiwatch 2; Phillips Respironics, which resembles a wrist watch, on their non-dominant wrist. A motion detection device located within the actigraph records movement. After data is collected it will be analyzed using a software program which uses a series of logarithms to measure various factors associated with sleep quality, such as total sleep duration, sleep efficiency, sleep onset latency, and the number of times participants woke during the night. Wrist actigraphy has been used to reliably differentiate the sleeping patterns of men and women. For the present study, participants will be asked to wear the actigraph from baseline assessment throughout the study through week eight. Participants will also complete a Daily Sleep Diary that will be used to help interpret wrist actigraphy data.

    Eight weeks

Secondary Outcomes (9)

  • PHQ-8

    Screening

  • Pittsburgh Sleep Quality Index (PSQI)

    Baseline, Week 4, Week 6, Week 8

  • Insomnia Severity Index (ISI)

    Baseline, Week 4, Week 6, Week 8

  • Epworth Sleepiness Scale (ESS)

    Baseline, Week 4, Week 6, Week 8

  • Menopausal Rating Scale (MRS)

    Baseline, Week 4, Week 6, Week 8

  • +4 more secondary outcomes

Study Arms (4)

5 Therapist-Delivered Hypnosis Session

ACTIVE COMPARATOR

Participants will complete five therapist-delivered hypnosis relaxation sessions with a hypnosis research therapist, and receive five audio (CD or MP3) recordings of hypnotic inductions and instructed in daily home practice.

Other: Hypnosis

3 Therapist-Delivered Hypnosis Session

ACTIVE COMPARATOR

Participants will complete three therapist-delivered hypnosis relaxation sessions with a hypnosis research therapist, and receive five audio (CD or MP3) recordings of hypnotic inductions and instructed in daily home practice.

Other: Hypnosis

5 Phone Calls; Hypnosis Recordings Only

ACTIVE COMPARATOR

Participants will complete five phone calls with a hypnosis research therapist, and receive five audio (CD or MP3) recordings of hypnotic inductions and instructed in daily home practice.

Other: Hypnosis

3 Phone Calls; Hypnosis Recordings Only

ACTIVE COMPARATOR

Participants will complete three phone calls with a hypnosis research therapist, and receive five audio (CD or MP3) recordings of hypnotic inductions and instructed in daily home practice.

Other: Hypnosis

Interventions

Hypnosis is a promising, but under-studied non-pharmacological treatment option for poor sleep during the menopausal transition. Hypnosis is a mind-body therapy that may be defined as a deeply relaxed state involving mental imagery and suggestion. The hypnotic state has been described variously as being an altered state of consciousness, focused attention, imaginative involvement, and role assumption. However, it is generally agreed that hypnosis is a "state or condition, which occurs when appropriate suggestions elicit distortions of perception, memory, or mood". Research has shown that most people are hypnotizable. Hypnosis intervention for managing chronic symptoms usually involves a hypnotic induction, instruction in self-hypnosis and practice using audio recordings.

Also known as: Hypnotic Relaxation Therapy
3 Phone Calls; Hypnosis Recordings Only3 Therapist-Delivered Hypnosis Session5 Phone Calls; Hypnosis Recordings Only5 Therapist-Delivered Hypnosis Session

Eligibility Criteria

Age40 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females, aged 40-65. (This proposed range is based on the Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) criteria to identify symptomatic women in the menopausal transition and to allow for comparison to other studies of this target population)
  • Self-reported sleep duration of ≤6 hours per day/night for 5 or more nights per week as determined by a 7-day sleep diary during screening and baseline weeks
  • Post-menopausal or in the late perimenopausal transition, defined as ≥ 2 missed menstrual cycles with an interval of amenorrhea ≥ 60 days in the past 12 months
  • In general good health as determined by medical history and physical measures
  • Non-depressed as determined by Patient Health Questionnaire (PHQ-8) scores ≤ 9
  • Signed informed consent

You may not qualify if:

  • Use of hormone therapy or hormonal contraceptives during the 2 months before enrollment and for the duration of the study
  • Self-report of sleep apnea and/or restless leg syndrome
  • Use of any prescription or over-the-counter therapy for sleep (i.e. Melatonin, valerian, other "natural" sleep aids, and commonly used over-the-counter (OTC) medications \[e.g. acetaminophen + diphenhydramine or equivalent\]) \[NOTE: Medications not intended for sleep but that have a known impact on sleep will be allowed (i.e. serotonin-norepinephrine reuptake inhibitors-SNRIs, selective serotonin re-uptake inhibitors-SSRIs)\]
  • Severe or unstable medical or psychiatric illness
  • Current use of hypnosis for any condition
  • Inability to speak or understand English \[NOTE: Providing hypnosis is highly dependent on the use of language. While it would be possible to recruit a Spanish speaking hypnotherapist, none of the investigators speak Spanish and this would make it extremely difficult (if not unethical) to provide supervision to a Spanish speaking hypnotherapist. Because of this we have elected to restrict participants to those that are English speaking\]

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mind-Body Medicine Research Lab-Baylor University

Waco, Texas, 76798, United States

Location

Related Publications (2)

  • Elkins GR, Fisher WI, Johnson AK, Carpenter JS, Keith TZ. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause. 2013 Mar;20(3):291-8. doi: 10.1097/gme.0b013e31826ce3ed.

    PMID: 23435026BACKGROUND
  • Elkins G. Hypnotic Relaxation Therapy: Principles and Applications. New York, NY: Springer Publishing Company; 2013.

    BACKGROUND

Related Links

MeSH Terms

Conditions

Hot Flashes

Interventions

Hypnosis

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Gary R Elkins, PhD

    Baylor University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

July 9, 2014

First Posted

July 11, 2014

Study Start

December 1, 2014

Primary Completion

February 24, 2017

Study Completion

February 24, 2017

Last Updated

April 13, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations